Ignite Creation Date:
2024-10-25 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06521788
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-22
Brief Title:
Artificial Intelligence Assisted Breast Ultrasound in Breast Cancer Screening
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Application Research of B-ultrasound Assisted by Artificial Intelligence in Breast Cancer Screening
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AIBU
Brief Summary:
AIBU is a randomized open-label study assessing the effectiveness of an articificial intelligence-assisted breast ultrasound breast cancer screening strategy compared to standard screening according to the current local guidelines in each participating area in detecting late-stage breast cancers
Detailed Description:
we enrolled asymptomatic women Women From January 2021 to December 2022 and then followed up for the next 1 year The main study endpoint will be measured at the end of the one year after intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None